반응 #85777

ord-9656e271c98e45ed938035bf9a753ab9

용매

반응 조건

상세 조건
See reaction.notes.procedure_details.

후처리

  1. 1
    기타The resulting reaction mixture
  2. 2
    workup.STIRRINGto stir 2 hr at RT
  3. 3
    workup.STIRRINGto stir 1.5 hr at RT
  4. 4
    기타Reaction
  5. 5
    기타was quenched by the addition of a saturated solution of NH4Cl and EtOAc
  6. 6
    기타The phases were partitioned
  7. 7
    추출aqueous phase extracted with EtOAc
  8. 8
    세척washed with brine
  9. 9
    건조dried (Na2SO4)
  10. 10
    여과filtered
  11. 11
    농축concentrated to a yellow residue
  12. 12
    workup.DISSOLUTIONResidue dissolved in DMSO
  13. 13
    기타purified by reverse phase HPLC
  14. 14
    온도frozen

실험 절차

To a round bottom flask containing (S)-4-((R)-1-azidoethyl)-3-(2-(((S)-1-(2-(4-chlorophenyl)thiazol-5-yl)ethyl)amino)pyrimidin-4-yl)oxazolidin-2-one (14 mg, 0.03 mmol) and stir bar was added THF (1 mL) and trimethylphosphine (0.06 mL, 0.06 mmol, 1.0 M in THF). The resulting reaction mixture allowed to stir 2 hr at RT. A second addition of trimethylphosphine (0.06 mL, 0.06 mmol) occurred and the mixture allowed to stir 1.5 hr at RT. Reaction was quenched by the addition of a saturated solution of NH4Cl and EtOAc. The phases were partitioned and aqueous phase extracted with EtOAc. Organic phases combined and washed with brine, dried (Na2SO4), filtered and concentrated to a yellow residue. Residue dissolved in DMSO and purified by reverse phase HPLC. Product fractions combined, frozen and lyopholyzed to afford (S)-4-((R)-1-aminoethyl)-3-(2-(((S)-1-(2-(4-chlorophenyl)thiazol-5-yl)ethyl)amino)pyrimidin-4-yl)oxazolidin-2-one (2.6 mg, 4.60 μmol, 15% yield) as a TFA salt.

출처

DOI: 10.6084/m9.figshare.5104873.v1특허: US09434719B2uspto-grants-2016_09